The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
UGT2A 和 3A 代谢酶与烟草相关癌症风险
基本信息
- 批准号:9278174
- 负责人:
- 金额:$ 62.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:Aerodigestive TractAffectAlternative SplicingAromatic Polycyclic HydrocarbonsBenzo(a)pyreneButanonesCancer PatientCarcinogen MetabolismCarcinogensCase-Control StudiesCell LineCharacteristicsDataDiseaseDrug Metabolic DetoxicationEnzymesExhibitsExonsFamilyFundingGene Expression RegulationGenesGenetic PolymorphismGenotypeGlucuronidesGlucuronosyltransferaseGoalsHead CancerHead and Neck CancerHead and neck structureHigh-Risk CancerIn VitroIndividualIndividual DifferencesKineticsLarynxLiverLungLung AdenocarcinomaLymphocyteMalignant NeoplasmsMalignant neoplasm of lungMicrosomesNeck CancerNitrosaminesOrganPatternPhasePhenotypePlayPredispositionPrevention strategyProteinsPublishingRNA SplicingRegulationRespiratory SystemRespiratory tract structureRiskRisk FactorsRoleSiteSmokingSpecimenTestingTexasTissuesTobaccoTobacco smokeTobacco useTobacco-Associated CarcinogenTobacco-Related CarcinomaTranscriptUGT1A1 geneUnited States National Institutes of HealthVariantbasecancer riskcarcinogenesiscohortenzyme activityglycosyltransferasehuman tissueinnovationmemberphenotypic biomarkerpublic health relevancerespiratoryvalidation studies
项目摘要
DESCRIPTION (provided by applicant): Abstract Smoking and tobacco use are major risk factors for many diseases including lung and head and neck (H&N) cancer. A long term goal is to establish susceptibility markers for lung and H&N cancer to identify tobacco users at higher risk for these cancers. UDP-glycosyltransferase (UGT) enzymes play a critical role in the detoxification of many carcinogens abundant in tobacco and/or tobacco smoke including polycyclic aromatic hydrocarbons (PAHs) and tobacco-specific nitrosamines (TSNAs). Preliminary data suggest that members of the minimally-studied UGT2A and 3A sub-families of metabolizing enzymes are expressed in tobacco target tissues including lung and H&N, exhibit activity against tobacco carcinogens, and that polymorphic and splicing variants exist that alter their activity, thus potentially altering local detoxification of tobacco carcinogens at these targt sites. These characteristics suggest that UGT2A and 3A enzymes are potentially important susceptibility markers for tobacco-related cancers. The goal of this proposal is to test our hypothesis that UGT2A and 3A activity is important in the local detoxification of tobacco carcinogens in tobacco target tissues, and that UGT2A and 3A activities and expression are altered via genotypic and splicing mechanisms and play a role in risk of tobacco-related cancers. The specific aims of this proposal are to, (1) Characterize the expression and activity of UGT2A and 3A enzymes; (2) Examine the importance of UGT2A and 3A SNPs to risk for cancers of the lung and H&N; and (3) Examine UGT2A and 3A splicing mechanisms as a form of UGT2A and 3A regulation by determining whether UGT2A and 3A splice variants function to regulate UGT conjugating activities and potentially act to alter tobacco-related cancer risk. The proposed studies will enable us to better understand the potential role of the UGT2A and 3A enzymes as susceptibility markers for tobacco- related cancer induction, help us identify subjects for targeted prevention strategies, and enable us to evaluate the innovative concept that differential splicing may act as a form of gene regulation that plays a role in cancer risk.
描述(由申请人提供): 摘要 吸烟和烟草使用是许多疾病的主要危险因素,包括肺癌和头颈癌 (H&N)。长期目标是建立肺癌和头颈癌的易感性标记物,以识别较高水平的烟草使用者。 UDP-糖基转移酶 (UGT) 在烟草和/或烟草烟雾中丰富的许多致癌物(包括多环芳烃)的解毒中发挥着关键作用。 (PAH) 和烟草特有的亚硝胺 (TSNA) 初步数据表明,代谢酶 UGT2A 和 3A 亚家族的成员在包括肺和 H&N 在内的烟草靶组织中表达,表现出对抗烟草致癌物的活性。多态性和剪接的存在改变了它们的活性,从而可能改变烟草致癌物在这些目标位点的局部解毒作用。这些特征表明。 UGT2A 和 3A 酶是烟草相关癌症的潜在重要易感性标志物 该提案的目的是检验我们的假设,即 UGT2A 和 3A 活性在烟草靶组织中烟草致癌物的局部解毒中很重要,并且 UGT2A 和 3A 具有重要作用。活性和表达通过基因型和剪接机制发生改变,并在烟草相关癌症的风险中发挥作用。该提案的具体目的是:(1) 表征。 UGT2A 和 3A 酶的表达和活性;(2) 检查 UGT2A 和 3A SNP 对肺癌和 H&N 癌症风险的重要性;以及 (3) 检查 UGT2A 和 3A 剪接机制作为 UGT2A 和 3A 调节的一种形式;确定 UGT2A 和 3A 剪接变体是否具有调节 UGT 结合活性并可能改变烟草相关癌症风险的作用。我们可以更好地了解 UGT2A 和 3A 酶作为烟草相关癌症诱发的易感性标记的潜在作用,帮助我们确定有针对性的预防策略的对象,并使我们能够评估差异剪接可能作为基因的一种形式的创新概念在癌症风险中发挥作用的监管。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip Lazarus其他文献
Philip Lazarus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip Lazarus', 18)}}的其他基金
Gene-tobacco carcinogen interactions and lung cancer risk - a novel approach for precision cancer prevention
基因-烟草致癌物相互作用和肺癌风险——精准癌症预防的新方法
- 批准号:
10581340 - 财政年份:2022
- 资助金额:
$ 62.66万 - 项目类别:
The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
UGT2A 和 3A 代谢酶与烟草相关癌症风险
- 批准号:
9131748 - 财政年份:2015
- 资助金额:
$ 62.66万 - 项目类别:
The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
UGT2A 和 3A 代谢酶与烟草相关癌症风险
- 批准号:
9221216 - 财政年份:2015
- 资助金额:
$ 62.66万 - 项目类别:
Role of pharmacogenetics on exemestane metabolism and toxicity
药物遗传学对依西美坦代谢和毒性的作用
- 批准号:
8727490 - 财政年份:2012
- 资助金额:
$ 62.66万 - 项目类别:
Role of pharmacogenetics on exemestane metabolism and toxicity
药物遗传学对依西美坦代谢和毒性的作用
- 批准号:
8915094 - 财政年份:2012
- 资助金额:
$ 62.66万 - 项目类别:
Role of pharmacogenetics on exemestane metabolism and toxicity
药物遗传学对依西美坦代谢和毒性的作用
- 批准号:
8372081 - 财政年份:2012
- 资助金额:
$ 62.66万 - 项目类别:
Role of pharmacogenetics on exemestane metabolism and toxicity
药物遗传学对依西美坦代谢和毒性的作用
- 批准号:
8527745 - 财政年份:2012
- 资助金额:
$ 62.66万 - 项目类别:
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
UDP-葡萄糖醛酸基转移酶基因型和癌症风险
- 批准号:
7265009 - 财政年份:2007
- 资助金额:
$ 62.66万 - 项目类别:
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
UDP-葡萄糖醛酸基转移酶基因型和癌症风险
- 批准号:
7612146 - 财政年份:2007
- 资助金额:
$ 62.66万 - 项目类别:
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
UDP-葡萄糖醛酸基转移酶基因型和癌症风险
- 批准号:
8064730 - 财政年份:2007
- 资助金额:
$ 62.66万 - 项目类别:
相似国自然基金
GSE1选择性剪接激活PI3K/Akt通路调控脂质代谢影响衰老进程的机制研究
- 批准号:82360286
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
PTBP1选择性剪接对Nogo/NgR信号的影响及其在PTSD靶向治疗中的作用与机制研究
- 批准号:82372508
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
UHRF1/DNMT1-MZF1轴调控PRSS3选择性剪接影响非小细胞肺癌功能异质性的表观机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
mRNA选择性剪接和2′-O-甲基化修饰对植物抗病基因多样性影响及对抗病功能调控的研究
- 批准号:32170218
- 批准年份:2021
- 资助金额:61 万元
- 项目类别:面上项目
遗传变异调控选择性剪接影响肺腺癌发生的分子流行病学研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Illuminating multiplexed RNA dynamics to interrogate splicing in health and disease
阐明多重 RNA 动力学以探究健康和疾病中的剪接
- 批准号:
10713923 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine Users
研究导致可卡因吸食者中艾滋病毒持续存在的宿主基因亚型
- 批准号:
10788990 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Role of RNA helicase Ddx5 in pathological cardiac remodeling
RNA解旋酶Ddx5在病理性心脏重塑中的作用
- 批准号:
10718560 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别: